Tržní kapitalizace společnosti Alimera Sciences
Jaká je hodnota metriky Tržní kapitalizace společnosti Alimera Sciences?
Hodnota metriky Tržní kapitalizace společnosti Alimera Sciences Inc. je $16.83M
Jaká je definice metriky Tržní kapitalizace?
Tržní kapitalizace (Market cap) je tržní hodnotou vydaných akcií obchodované společnosti a rovná se ceně akcií v daném čase vynásobené počtem kusů vydaných akcií .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Tržní kapitalizace společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Alimera Sciences
Čemu se věnuje společnost Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Firmy s metrikou tržní kapitalizace podobnou společnosti Alimera Sciences
- Hodnota metriky Tržní kapitalizace společnosti O2i SA je $16.79M
- Hodnota metriky Tržní kapitalizace společnosti TNT Mines je $16.79M
- Hodnota metriky Tržní kapitalizace společnosti Miliboo SA je $16.79M
- Hodnota metriky Tržní kapitalizace společnosti e plc je $16.80M
- Hodnota metriky Tržní kapitalizace společnosti K2 F&B je $16.82M
- Hodnota metriky Tržní kapitalizace společnosti TDH Inc je $16.83M
- Hodnota metriky Tržní kapitalizace společnosti Alimera Sciences je $16.83M
- Hodnota metriky Tržní kapitalizace společnosti Travel Technology Interactive je $16.86M
- Hodnota metriky Tržní kapitalizace společnosti Okapi Resources je $16.86M
- Hodnota metriky Tržní kapitalizace společnosti Pantaflix AG je $16.87M
- Hodnota metriky Tržní kapitalizace společnosti Applied Genetic Technologies Corp je $16.87M
- Hodnota metriky Tržní kapitalizace společnosti Evgen Pharma plc je $16.87M
- Hodnota metriky Tržní kapitalizace společnosti UPERGY Societe Anonyme je $16.88M